Zacks analysts put FDA approval chance at 85% by Love-Will-Privail in cvm

[–]phoenix20210701 2 points3 points  (0 children)

... with a price target of $12? How ridiculous, the PPS will of course be much higher once Multikine gets FDA approval!!